Geode Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $6.99M | Buy |
|
|||||
|
2024
Q3 | $11.9M | Sell |
|
|||||
|
2024
Q2 | $5.91M | Buy |
|
|||||
|
2024
Q1 | $9.7M | Buy |
|
|||||
|
2023
Q4 | $16.9M | Buy |
|
|||||
|
2023
Q3 | $20.4M | Buy |
|
|||||
|
2023
Q2 | $42.9M | Buy |
|
|||||
|
2023
Q1 | $51.4M | Buy |
|
|||||
|
2022
Q4 | $28.3M | Buy |
|
|||||
|
2022
Q3 | $37.3M | Buy |
|
|||||
|
2022
Q2 | $17.1M | Sell |
|
|||||
|
2022
Q1 | $26.1M | Buy |
|
|||||
|
2021
Q4 | $21.4M | Buy |
|
|||||
|
2021
Q3 | $33.6M | Buy |
|
|||||
|
2021
Q2 | $35.7M | Buy |
|
|||||
|
2021
Q1 | $31.3M | Buy |
|
|||||
|
2020
Q4 | $28.1M | Buy |
|
|||||
|
2020
Q3 | $23.6M | Buy |
|
|||||
|
2020
Q2 | $19.5M | Buy |
|
|||||
|
2020
Q1 | $10.7M | Buy |
|
|||||
|
2019
Q4 | $9.53M | Buy |
|
|||||
|
2019
Q3 | $7.5M | Buy |
|
|||||
|
2019
Q2 | $7.28M | Buy |
|
|||||
|
2019
Q1 | $7.7M | Buy |
|
|||||
|
2018
Q4 | $7.77M | Buy |
|
|||||
|
2018
Q3 | $8.39M | Buy |
|
|||||
|
2018
Q2 | $8.35M | Buy |
|
|||||
|
2018
Q1 | $8.08M | Buy |
|
|||||
|
2017
Q4 | $7.85M | Buy |
|
|||||
|
2017
Q3 | $5.59M | Buy |
|
|||||
|
2017
Q2 | $5.07M | Buy |
|
|||||
|
2017
Q1 | $3.71M | Buy |
|
|||||
|
2016
Q4 | $3.17M | Buy |
|
|||||
|
2016
Q3 | $2.4M | Buy |
|
|||||
|
2016
Q2 | $1.95M | Buy |
|
|||||
|
2016
Q1 | $2.44K | Buy |
|
|||||
|
2015
Q4 | $4.4M | Buy |
|
|||||
|
2015
Q3 | $2.88M | Buy |
|
|||||
|
2015
Q2 | $2.47M | Buy |
|
|||||
|
2015
Q1 | $1.47M | Buy |
|
|||||
|
2014
Q4 | $1.1M | Buy |
|
|||||
|
2014
Q3 | $1.22M | Buy |
|
|||||
|
2014
Q2 | $1.39M | Buy |
|
|||||
|
2014
Q1 | $1.11M | Buy |
|